Prenatal Neurosurgical Counseling for Myelomeningocele and Treatment-Determining Factors for Fetal Repair

Belinda Shao1, Christian Schroeder1, Emilija Sagaityte1

  • 1Department of Neurosurgery, Warren Alpert Medical School of Brown University, Providence, Rhode Island, USA.

PubMed

Insights

Neurosurgical prenatal counseling (nPNC) for spina bifida (myelomeningocele) was timely for most families. Few modifiable factors deterred patients from fetal repair, indicating effective prenatal care for myelomeningocele (MMC).

Area of Science:

  • Fetal Medicine
  • Pediatric Neurosurgery
  • Maternal-Fetal Medicine

Background:

  • Spina bifida guidelines emphasize neurosurgical involvement in prenatal counseling.
  • Informed decision-making between prenatal and postnatal myelomeningocele (MMC) repair is crucial.
  • This study evaluates the timeliness and factors influencing neurosurgical prenatal counseling (nPNC) for MMC.

Purpose of the Study:

  • To assess the timeliness of nPNC for families with MMC at a fetal center.
  • To identify modifiable and non-modifiable factors influencing treatment decisions.
  • To evaluate patient selection for prenatal versus postnatal MMC repair.

Main Methods:

  • Quantified nPNC history and timing for MMC repair cases (2015-2023).
  • Assessed fetal repair exclusions, presentation timing, and social determinants.
  • Analyzed reasons for declining offered fetal therapy.

Main Results:

  • 97% of patients received nPNC, with 82% before 24 weeks gestation.
  • Common fetal repair exclusions included lack of hindbrain herniation (43%) and obstetric factors (21%).
  • Among eligible patients, 50% chose fetal repair, 45% postnatal repair, and 5% termination; risk (55%) and cost (22%) were key reasons for declining fetal repair.

Conclusions:

  • Neurosurgical prenatal counseling (nPNC) was broadly accessible and timely for families with MMC.
  • Potentially modifiable barriers minimally impacted decisions regarding fetal repair.
  • The study highlights effective prenatal care delivery for myelomeningocele (MMC).
Abstract